Figure 4: UV-Spectral comparison of TMD, DMP and PCM. (a1,, a2 and a3), bulk of TMD, DMP and PCM, (b1, b2 and b3) tablet formulation A and TMD, DMP and PCM, (c1, c2 and c3) tablet formulation B respectively.